Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Naohiro HAKAMATA
Cardiac .BETA.-Adrenergic Signaling Pathway Alteration in Isoproterenol-Induced Cardiac Hypertrophy in Male Sprague-Dawley Rats.
Japanese Heart Journal
Related publications
Simvastatin Prevents Isoproterenol-Induced Cardiac Hypertrophy Through Modulation of the JAK/STAT Pathway
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Isoproterenol-Induced Cardiac Hypertrophy: Role of Circulatory Versus Cardiac Renin-Angiotensin System
American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular Medicine
Physiology
Cardiology
Role of Cardiac Angiotensin II in Isoproterenol-Induced Left Ventricular Hypertrophy.
Hypertension
Internal Medicine
Β2 Adrenergic Signaling of Cardiac Fibroblasts Induces Cardiac Hypertrophy Through Paracrine System
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Effect of Vildagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Cardiac Hypertrophy Induced by Chronic Beta-Adrenergic Stimulation in Rats
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
AKAP-Lbc Mobilizes a Cardiac Hypertrophy Signaling Pathway
Molecular Cell
Cell Biology
Molecular Biology
Evaluation of Anti-Hypertrophic Potential of Camellia Sinensis in Isoproterenol Induced Cardiac Hypertrophy
International Journal of Pharmacy and Pharmaceutical Sciences
Pharmacology
Pharmaceutical Science
Regression of Isoproterenol-Induced Cardiac Hypertrophy by Na+/H+ Exchanger Inhibition
Hypertension
Internal Medicine
The Remedial Efficacy of Spirulina Platensis Versus Chromium-Induced Nephrotoxicity in Male Sprague-Dawley Rats
PLoS ONE
Multidisciplinary